Novavax

NVAX

NVAX Novavax NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    NVAX Chart
    See on advanced chart >

    About

    Novavax, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The company's vaccine technology platform is based on proprietary recombinant...
    • Highlight
      A world's leading COVID-19 vaccine development company
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/01/2001
    • Established Date
      Invalid Date
    • Full-time Employees
      1,992
    • Address
      20 Firstfield Road Gaithersburg Maryland 20878
    • Tel
      1-240-2682000
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-02-23 00:42:58